| Revenues | | 1,065.37 | 751.05 | 777.68 | 519.05 |
| Cost Of Revenue | | 709.79 | 525.51 | 537.79 | 367.37 |
| Gross Profit | | 355.57 | 225.54 | 239.90 | 151.68 |
| | 173.34 | 153.35 | 152.37 | 143.83 |
| Research and Development | | 58.87 | 56.85 | 55.89 | 48.72 |
| Operating Income/Loss | | 182.24 | 72.19 | 87.53 | 7.85 |
| Income/Loss From Equity Method Investments | | 4.35 | -17.00 | -20.82 | -19.60 |
| Income/Loss From Continuing Operations Before Tax | | 200.33 | 74.14 | 2.38 | -22.62 |
| Income Tax Expense/Benefit | | 1.47 | 0.45 | 0.95 | 0.34 |
| | 198.86 | 73.69 | 1.43 | -22.96 |
| Available To Common Stockholders, Basic | | 196.29 | 70.65 | 1.09 | -23.09 |
| Attributable To Noncontrolling Interest | | 2.57 | 3.04 | 0.33 | 0.13 |
| Basic Average Shares | | 287.29 | 281.72 | 7.82 | 234.93 |
| Diluted Average Shares | | 323.33 | 319.71 | 7.82 | 234.93 |
| Basic Earnings Per Share | | 0.68 | 0.25 | 379.63 | -100.00 |
| Diluted Earnings Per Share | | 0.62 | 0.23 | 379.63 | -100.00 |